Indirect tolerability comparison of Deutetrabenazine and Tetrabenazine for Huntington disease
about
Deutetrabenazine: A Review in Chorea Associated with Huntington's Disease.Meta-research metrics matter: letter regarding article "indirect tolerability comparison of Deutetrabenazine and Tetrabenazine for Huntington disease".Deutetrabenazine for tardive dyskinesia: A systematic review of the efficacy and safety profile for this newly approved novel medication-What is the number needed to treat, number needed to harm and likelihood to be helped or harmed?Treatment options for chorea.Review of deutetrabenazine: a novel treatment for chorea associated with Huntington's disease.Huntington’s Disease Clinical Trials Corner: February 2018
P2860
Indirect tolerability comparison of Deutetrabenazine and Tetrabenazine for Huntington disease
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Indirect tolerability comparis ...... enazine for Huntington disease
@en
Indirect tolerability comparis ...... nazine for Huntington disease.
@nl
type
label
Indirect tolerability comparis ...... enazine for Huntington disease
@en
Indirect tolerability comparis ...... nazine for Huntington disease.
@nl
prefLabel
Indirect tolerability comparis ...... enazine for Huntington disease
@en
Indirect tolerability comparis ...... nazine for Huntington disease.
@nl
P2093
P2860
P1476
Indirect tolerability comparis ...... enazine for Huntington disease
@en
P2093
Benjamin Carroll
Daniel O Claassen
David Stamler
Lisa M De Boer
Rajeev Ayyagari
Sanjay Gandhi
P2860
P2888
P356
10.1186/S40734-017-0051-5
P577
2017-03-01T00:00:00Z
P6179
1083941659